Alireza Khodadadi-Jamayran Selected Research

Alireza Khodadadi-Jamayran Research Topics

Disease

16	Neoplasms (Cancer) 11/2023 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2018
2	Leukemia 01/2022 - 01/2020
2	Carcinogenesis 01/2018 - 12/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 12/2017
2	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2016 - 11/2015
1	Premature Aging 11/2023
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 11/2023
1	Inflammation (Inflammations) 11/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Dysbiosis 01/2022
1	COVID-19 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Infections 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Heart Failure 01/2021
1	Nephritis 01/2021
1	Lupus Nephritis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	T-Cell Leukemia (Leukemia, T Cell) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Brain Neoplasms (Brain Tumor) 12/2017
1	Hematologic Neoplasms (Hematological Malignancy) 10/2016
1	Necrosis 04/2016
1	Friedreich Ataxia (Friedreich's Ataxia) 01/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2018
4	ChromatinIBA 11/2021 - 12/2017
3	Histones (Histone)IBA 01/2018 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 11/2021
2	LigandsIBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 01/2021
2	AntigensIBA 11/2021 - 01/2021
2	MethyltransferasesIBA 01/2018 - 10/2016
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Chemokine CXCL13IBA 01/2023
1	OsteopontinIBA 01/2023
1	InterleukinsIBA 11/2022
1	Interleukin-15 (Interleukin 15)IBA 11/2022
1	A-factor (Streptomyces)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	AerosolsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	InterferonsIBA 11/2021
1	Histone-Lysine N-MethyltransferaseIBA 11/2021
1	erucylphosphocholineIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Proteasome InhibitorsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Histone ChaperonesIBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	CRISPR-Cas Systems Guide RNAIBA 01/2020
1	Ubiquitin-Specific Peptidase 7IBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	H3B-8800IBA 01/2020
1	Histone Deacetylase 2IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	Proteoglycans (Proteoglycan)IBA 02/2018
1	MicroRNAs (MicroRNA)IBA 02/2018
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2018
1	TensinsIBA 12/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2017
1	EpitopesIBA 04/2016
1	Antisense RNA (Anti-Sense RNA)IBA 01/2016
1	FrataxinIBA 01/2016
1	Phosphotransferases (Kinase)IBA 09/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2015
2	Immunotherapy 11/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 11/2022
1	Transplantation 01/2022